DST antisense RNA 1 (DST-AS1)

DST antisense RNA 1 (DST-AS1) is a long non-coding RNA molecule transcribed from the antisense strand of the DST gene locus. Antisense RNAs such as DST-AS1 are typically involved in the regulation of gene expression at the transcriptional or post-transcriptional level by mechanisms such as mRNA hybridization, which can influence stability or translation of the corresponding sense transcript[3]. There is currently no experimental literature describing the specific biological function, disease association, or druggability of DST-AS1, and it is not recognized as a therapeutic target in human disease[1][3]. Context and key details: - DST-AS1 is listed in gene annotation databases, but with minimal annotation: no described protein product, functional data, or disease linkage[1]. - The NAT and lncRNA classes are collectively studied for their gene regulatory roles, but DST-AS1 itself is not yet characterized[3][1]. - If seeking a related antisense lncRNA with established disease function, *DSCAM-AS1* (from the DSCAM locus, not DST) is characterized in cancer[4], but this is distinct from DST-AS1. Summary: DST-AS1 is a long non-coding antisense RNA of unknown function, not considered a canonical drug target, with no validated therapeutic, clinical, or biomarker roles as of the latest available data.

Other names

DST-AS1